GAS5 and non-small cell lung carcinoma: Several lines of evidence indicated that GAS5 was implicated and aberrantly expressed in multiple cancers, such as breast cancer, hepatocellular carcinoma, gastric cancer, bladder cancer and non-small-cell lung cancer (NSCLC) [6, 12, 16, 22, 24].